Management of High-Risk Localized Prostate Cancer
Traditionally, patients with high-risk localized prostate cancer have been an extremely challenging group to manage due to a significant likelihood of treatment failure and prostate cancer-specific mortality (PCSM). The results of multiple large, prospective, randomized trials have demonstrated that...
Main Authors: | Ariel E. Marciscano, Matthew E. Hardee, Nicholas Sanfilippo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/641689 |
Similar Items
-
High-Risk Localized and Locally Advanced Prostate Cancer
Published: (2023) -
Surgery for high-risk localized prostate cancer
by: Jan Schmitges, et al.
Published: (2011-08-01) -
A multifaceted precision approach to high risk localized prostate cancer
by: S. Alinezhad, et al.
Published: (2020-07-01) -
Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
by: Nicholas G. Zaorsky, et al.
Published: (2020-08-01) -
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009-06-01)